Save
What can PARP inhibition maintenance therapy offer to ovarian cancer patients?
ESGO eAcademy, Isabelle Ray-Coquard, 233820
Keynote - The EU perspective on rare cancers
ESGO eAcademy, Jean Yves Blay, 232406
Treatment of vulvo-vaginal melanoma: experience with moderm immunotherapy
ESGO eAcademy, Ronnie Shapira-Frommer, 232405
A multicentre analysis of malignant ovarian germ cell tumours: rationale for alignment of paediatric and adult practice and for chemotherapy de-escalation in specific subtypes
ESGO eAcademy, Michelle Lockley, 232404
Therapeutic opportunities in mucinous ovarian carcinoma
ESGO eAcademy, Kylie Gorringe, 232403
Influence of single and multi-agent chemotherapy on ovarian function and fertility in patients with gestational trophoblastic neoplasia
ESGO eAcademy, Daniela Giuliani, 232402
Surgical fertility sparing management of uterine tumors
ESGO eAcademy, Frederic Amant, 232432
Small cell carcinoma of ovary
ESGO eAcademy, Antonio Gonzalez, 232401
Female germ cell tumours
ESGO eAcademy, Michael Seckl, 232400
Squamous cancers arising in teratoma
ESGO eAcademy, Domenica Lorusso, 232399
Sex cord-stromal tumours
ESGO eAcademy, Isabelle Ray-Coquard, 232398
Mucinous cancers and pseudomyxoma peritoneii
ESGO eAcademy, Ate van der Zee, 232397
Clear cell ovarian cancer
ESGO eAcademy, Jonathan Ledermann, 232396
Low grade serous tumours
ESGO eAcademy, Ana Oaknin, 232395
Keynote - Pathology of low grade tumours
ESGO eAcademy, Glenn McCluggage, 232394
Hereditary syndromes, genetic testing and gynaecological cancers
ESGO eAcademy, Nicoletta Colombo, 232393
​Fertility preserving strategies in rare ovarian cancers
ESGO eAcademy, Philippe Morice, 232392
Biomarkers - prognostic and predictive
ESGO eAcademy, Jonathan Ledermann, 232391
Keynote - Molecular genetics of rare gynaecological cancers
ESGO eAcademy, David Huntsman, 232390
Quality of life and late treatments effects
ESGO eAcademy, Florence Joly, 232389
National and international registries & epidemiology
ESGO eAcademy, Domenica Lorusso, 232388
Approaches to treatment - organisation and central review
ESGO eAcademy, Mojgan Devouassoux, 232387
ESGO-ESMO Consensus conference on ovarian cancer standard treatment: final recommendations
ESGO eAcademy, Nicoletta Colombo, 232386
ESMO-ESGO Consensus Conference on Ovarian Cancer
ESGO eAcademy, Denis Querleu, 234269
Safety monitoring for long term benefit and QoL
ESGO eAcademy, Cristiana Sessa, 232430
Radical hysterectomy type C1
ESGO eAcademy, Henrik Falconer, 225605
Gynecologic Oncology Surgery for the treatment of Congenital Cervical Agenesis
ESGO eAcademy, Basilio Pecorino, 225040
Management of non-epithelial ovarian malignancies
ESGO eAcademy, Cristiana Sessa, 219071
Adjuvant treatment in early, advanced and recurrent ovarian cancer
ESGO eAcademy, Mansoor Mirza, 219382
Video: surgical procedures in advanced ovarian cancer
ESGO eAcademy, Christina Fotopoulou, 219070
Surgical management of primary and recurrent ovarian cancer
ESGO eAcademy, Denis Querleu, 219381
Epidemiology and histopathology of ovarian cancer
ESGO eAcademy, Piotr Bernaczyk, 219069
Diagnosis and staging of ovarian cancer
ESGO eAcademy, Anna Fagotti, 219068
Management of surgical complications
ESGO eAcademy, Christina Fotopoulou, 219066
Symptom control and pain management (palliative care)
ESGO eAcademy, Cristiana Sessa, 219065
Perioperative care
ESGO eAcademy, Christina Fotopoulou, 219064
Familial gynecological cancer: risk assessment and management
ESGO eAcademy, Fedro Alessandro Peccatori, 219383
Diagnosis and management of uterine sarcoma
ESGO eAcademy, Michael J. Halaska, 219063
Fertility preserving options in endometrial cancer
ESGO eAcademy, Pawel Knapp, 219062
Video: laparoscopic paraaortic lymphadenectomy
ESGO eAcademy, Denis Querleu, 219061
Video: open paraaortic lymphadenectomy
ESGO eAcademy, Christina Fotopoulou, 219060
Adjuvant treatment of endometrial cancer
ESGO eAcademy, Mansoor Mirza, 219058
Surgical management of endometrial cancer
ESGO eAcademy, Denis Querleu, 219057
Diagnosis in endometrial cancer
ESGO eAcademy, Pawel Knapp, 219056
Epidemiology and histopathology of hyperplasia and endometrial cancer
ESGO eAcademy, Jaroslaw Swatek, 219055
Video: Partial/radical vulvectomy and groin node dissection, SLNM
ESGO eAcademy, Michael J. Halaska, 219054
Management of advanced stage and recurrent vulvar cancer
ESGO eAcademy, Mansoor Mirza, 219053
Primary treatment of early stage vulvar cancer
ESGO eAcademy, Kamil Zalewski, 219052
Epidemiology and histopathology
ESGO eAcademy, Piotr Bernaczyk, 219051
Fertility sparing procedures in cervical carcinoma (trachelectomy, NAC)
ESGO eAcademy, Michael J. Halaska, 219050
Radical hysterectomy classification
ESGO eAcademy, David Cibula, 219049
Management of locally advanced carcinoma
ESGO eAcademy, Robert Jach, 219380
Cervical cancer: management of early invasive carcinoma
ESGO eAcademy, David Cibula, 219379
Ultrasound, MRI, staging in cervical cancer
ESGO eAcademy, Michael J. Halaska, 219046
Epidemiology and prevention of cervical cancer
ESGO eAcademy, Robert Jach, 219045
Surgical spaces, lymphatic drainage, nerves, topography
ESGO eAcademy, Denis Querleu, 219044
Management of bowel obstruction in patients with ovarian cancer
ESGO eAcademy, Sahar Salehi, 213404
Palliative chemotherapy for ovarian cancer patients – what should we palliate?
ESGO eAcademy, Torbjørn Paulsen, 213403
Palliative chemotherapy for cervical and endometrial cancer – What is the evidence?
ESGO eAcademy, Torbjørn Paulsen, 213401
Palliative sedation -guidelines and practical tips
ESGO eAcademy, Staffan Lundström, 213397
Psychological support for dying patients
ESGO eAcademy, Vesna I. Kesic, 213393
The place for relaps surgery in gynecological cancer patients
ESGO eAcademy, Henrik Falconer, 213391
Ureteral reconstruction and Urinary conduits
ESGO eAcademy, Luis M. Chiva, 209153
Bowel surgery 
ESGO eAcademy, David Cibula, 209152
Bowel preparation
ESGO eAcademy, Dimitrios Haidopoulos, 209151
Video Assisted Thoracoscopic Surgery (VATS)
ESGO eAcademy, Murat Gultekin, 209150
Stomach mobilization - resection - placement of J-tube
ESGO eAcademy, Jalid Sehouli, 209149
Dissection of Porta Hepatis, Celiac Trunk and Techniques for Cholecystectomy
ESGO eAcademy, Denis Querleu, 209148
Splenectomy and Distal Pancreatectomy
ESGO eAcademy, David Cibula, 209147
Diaphragm stripping - resection - repair
ESGO eAcademy, Anna Fagotti, 209146
Liver Mobilization & Cardio-Phrenic LND
ESGO eAcademy, Luis M. Chiva, 209145
Morbidity and postoperatieve outcome
ESGO eAcademy, Jalid Sehouli, 209144
Nutrition
ESGO eAcademy, Philippe Morice, 209143
Preoperative and Postoperative evaluation of the advanced ovarian cancer patient
ESGO eAcademy, Stephanie Suria, 209142
Modified posterior exenteration and Excision of the pouch of Douglas sparing the rectum
ESGO eAcademy, Philippe Morice, 209141
Pelvic and Paarotic llymphadenectomy
ESGO eAcademy, Denis Querleu, 209140
Evaluation of the extension of the disease
ESGO eAcademy, Anna Fagotti, 209139
Science of tissue management - energy and hemostats, stapplers, ednocutters
ESGO eAcademy, Dimitrios Haidopoulos, 209138
Surgery in advanced epithelial ovarian cancer - Quality control
ESGO eAcademy, Luis M. Chiva, 211211
The aim of cytoreduction in ovarian cancer surgery
ESGO eAcademy, Murat Gultekin, 209137
How to coordinate a successful longstanding cooperative group; the ICON experience.
ESGO eAcademy, Jonathan Ledermann, 256974
How to inform patients about participation in a clinical trial?
ESGO eAcademy, Cristiana Sessa, 256971
ESGO Exam / How to build an adequate CV?
ESGO eAcademy, Ignace Vergote, 256969
Investigator sponsored research; what are the responsibilities?
ESGO eAcademy, Cristiana Sessa, 256968
How to be a mentor to all stages of an oncologic surgeon's education; my experience
ESGO eAcademy, Denis Querleu, 256967
CURRENT AND FUTURE DIRECTIONS FOR GRANULOSA CELL TUMOUR MANAGEMENT
ESGO eAcademy, Isabelle Ray-Coquard, 202840
WHAT IS THE STATE-OF-THE-ART FOR OVARIAN GERM CELL TUMOURS?
ESGO eAcademy, Jalid Sehouli, 202839
HEREDITARY GYNAECOLOGICAL CANCERS: PREVENTION AND ROLE OF PROPHYLACTIC SURGERIES
ESGO eAcademy, Ranjit Manchanda, 202843
HOW CAN WE ELIMINATE DEATHS IN HIGH RISK GTN?
ESGO eAcademy, Michael Seckl, 202838
STATE OF ART IN SCREENING OF GYNAECOLOGICAL CANCERS
ESGO eAcademy, Murat Gultekin, 202842
RECENT DEVELOPMENTS IN GTD AND MOLAR PREGNANCIES
ESGO eAcademy, Leon Massuger, 202837
THE IMPACT OF HEALTHY LIFE STYLE AND OBESITY ON PREVENTION OF GYNAECOLOGICAL CANCERS
ESGO eAcademy, Maria Kyrgiou, 202841
LAPAROSCOPIC VERSUS OPEN TREATMENT OF ENDOMETRIAL CANCER IN ELDERLY WOMEN
ESGO eAcademy, Ignacio Zapardiel, 202833
PREDICTIVE MARKERS IN CERVICAL CANCER
ESGO eAcademy, Cornelis D de Kroon, 203136
ELDERLY PATIENTS UNDERGOING SURGERY FOR OVARIAN OR CERVICAL CANCER: PERI-OPERATIVE ASSESSMENT AND SURGICAL CHOICES
ESGO eAcademy, Dina Kurdiani, 202832
PREDICTIVE MARKERS IN OVARIAN CARCINOMA
ESGO eAcademy, Alexandra Leary, 202835
FRAILTY EVALUATION AND MEDICAL TREATMENT OF ELDERLY POPULATION WITH GYNAECOLOGICAL MALIGNANCIES
ESGO eAcademy, Annamaria Ferrero, 202831
PREDICTIVE MARKERS IN ENDOMETRIAL CARCINOMA
ESGO eAcademy, Xavier Matias-Guiu, 202834
SUPPORTIVE CARE FOR WOMEN WITH GYNAECOLOGIC CANCER RECEIVING EXTERNAL BEAM RADIOTHERAPY AND BRACHYTHERAPY
ESGO eAcademy, Alina Sturdza, 202830
SUPPORTIVE CARE IN GYNECOLOGIC CANCER PATIENTS RECEIVING MEDICAL TREATMENT
ESGO eAcademy, Jørn Herrstedt, 202829

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings